Marketing Portfolios Safety 
The Dermatology Digest
DECEMBER 18, 2024
The clinical results demonstrated that STEQEYMA and its reference product, ustekinumab, are highly similar, and have no clinically meaningful differences in terms of safety and efficacy. “STEQEYMA is now the latest biologic in our immunology portfolio, joining ZYMFENTRA (infliximab-dyyb). . immunology market.”
Southeastern Esthetics Institute
AUGUST 23, 2016
Specific courses for cosmetic lasers, for example, are crucial to add to the esthetics portfolio, in order to showcase added training beyond that of the esthetics fundamentals course. To be competitive in the current esthetics market, practitioners must obtain consistent continuing education in advanced esthetics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Dermatology Digest
SEPTEMBER 30, 2024
market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. Otulfi demonstrated comparable efficacy, safety, pharmacokinetics and immunogenicity to Stelara in patients with moderate to severe psoriasis vulgaris. This marks the fourth FDA-approved biosimilar for Stelara.
Spa Executive
JULY 17, 2024
Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces.
The Dermatology Digest
SEPTEMBER 9, 2024
“China has always been a strategic market for Sisram, and the approval of Daxxify serves as a key milestone for bringing Sisram’s high-end injectables portfolio to Mainland China,” says Mr. Liu Yi, Sisram Chairman and Executive Director, in a news release.
The Studio Academy of Beauty
MAY 31, 2023
The practical exam, on the other hand, assesses your technique, professionalism, and adherence to safety protocols, ensuring that you can effectively demonstrate and teach these skills to your students. Market your services: Promote your services through social media platforms. Offer promotions and specials to new and existing clients.
Aesthetics Advisor
SEPTEMBER 15, 2023
The pharmacology, toxicity, and safety data for NO use in humans has been well-established for decades. Moreover, Glenmark Pharmaceuticals received manufacturing and marketing approval for the Nitric Oxide Nasal Spray (NONS) as part of an accelerated approval process. Iota-carrageenan is a sugar that comes from algae.
Expert insights. Personalized for you.
69 
Let's personalize your content